Michelle Richardson
Associate Director, Patient-Centered Research & Clinical Outcome Assessment Otsuka
Seminars
Tuesday 17th March 2026
Shaping the Future of CKD Trials with Meaningful Patient-Reported Outcomes
5:00 pm
- Harmonizing clinician-designed PRO measures with what regulators (e.g., FDA/EMA) expect to ensure trial endpoints are accepted
- Ensuring PROs capture what matters to patients (symptoms, QoL, treatment burden) especially in early or mild CKD, not just lab or imaging changes
- Integrating PROs early in development (Phase II/POC) to inform Phase III design and labelling claims
- Leveraging real-world evidence and external controls to validate PRO metrics, reduce placebo arms, and speed regulatory approval
Tuesday 17th March 2026
Making CKD Clinical Trials More Accessible, Feasible & Patient-Centered: Bridging Research Goals with Real-World Realities
5:30 pm
- Understanding the broader patient experience from both patient, caregiver and clinician perspective
- Exploring the decision to participate in a clinical trial, and factors that may limit patient involvement
- Examining strategies to make trials more accessible to patients including geographical, financial and logistical barriers, while fostering open communication between researchers and participants
- Reducing burden for patients to participate in a clinical trial through innovative strategies
